We are live on ! Find out more
BDSI

BioDelivery Sciences International, Inc.

Delisted

BDSI was delisted on the 22nd of March, 2022.

145 hedge funds and large institutions have $284M invested in BioDelivery Sciences International, Inc. in 2020 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 53 increasing their positions, 41 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

432% more call options, than puts

Call options by funds: $851K | Put options by funds: $160K

29% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 41

13% more capital invested

Capital invested by funds: $252M → $284M (+$31.6M)

4% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 23

1% less funds holding

Funds holding: 147145 (-2)

Holders
145
Holders Change
-2
Holders Change %
-1.36%
% of All Funds
2.57%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
22
Increased
53
Reduced
41
Closed
23
Calls
$851K
Puts
$160K
Net Calls
+$691K
Net Calls Change
+$345K
Name Holding Trade Value Shares
Change
Change in
Stake
TRCT
101
Tower Research Capital (TRC)
New York
$70K -$337K -87,487 -84%
VF
102
Virtu Financial
New York
$70K +$63.9K +16,593 New
Victory Capital Management
103
Victory Capital Management
Texas
$67K +$3.85K +1,000 +7%
CNC
104
Canandaigua National Corp
New York
$66K +$5.75K +1,491 +10%
Federated Hermes
105
Federated Hermes
Pennsylvania
$64K +$52.3K +13,563 +826%
Bank of Montreal
106
Bank of Montreal
Ontario, Canada
$62K +$37.8K +9,817 +237%
Legal & General Group
107
Legal & General Group
United Kingdom
$59K
AB
108
Amalgamated Bank
New York
$59K +$247 +64 +0.5%
MLICM
109
Metropolitan Life Insurance Company (MetLife)
New York
$54.1K +$902 +234 +2%
Lazard Asset Management
110
Lazard Asset Management
New York
$54K
Zurich Cantonal Bank
111
Zurich Cantonal Bank
Switzerland
$54K
Simplex Trading
112
Simplex Trading
Illinois
$54K +$30.4K +7,892 +155%
CSM
113
CAMG Solamere Management
North Carolina
$50K +$45.1K +11,699 New
Prudential Financial
114
Prudential Financial
New Jersey
$47K
Rafferty Asset Management
115
Rafferty Asset Management
New York
$47K +$43K +11,146 New
Osaic Holdings
116
Osaic Holdings
Arizona
$43K -$2.49K -645 -6%
SI
117
Stephens Inc
Arkansas
$42K
Walleye Trading
118
Walleye Trading
New York
$42K +$38.9K +10,102 New
CAM
119
Close Asset Management
United Kingdom
$32K
AIP
120
Ameritas Investment Partners
Nebraska
$30K
Canada Life
121
Canada Life
Manitoba, Canada
$24K
PAM
122
Panagora Asset Management
Massachusetts
$24K +$925 +240 +4%
JFGIW
123
Johnson Financial Group Inc (Wisconsin)
Wisconsin
$21K
FCMT
124
Founders Capital Management (Texas)
Texas
$17K +$15.4K +4,000 New
EARNEST Partners
125
EARNEST Partners
Georgia
$12K

BDSI Hedge Fund Activity: Q4 2020 in Review

145 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q4 2020, worth a combined $284M — up 13% from $252M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of BDSI and 22 opened new positions — a net loss of 1 holder — while 41 trimmed existing stakes and 53 added.

The largest buyer was Wasatch Advisors, adding an estimated $9.73M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $7.27M sold.

  • 145 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q4 2020, down from 147 in Q3 2020.
  • Funds reported $284M of BioDelivery Sciences International, Inc. stock for Q4 2020, up 13% quarter-over-quarter.
  • 22 funds opened new BioDelivery Sciences International, Inc. positions in Q4 2020 and 23 closed out, a net change of -1 holder.
  • The largest BioDelivery Sciences International, Inc. buyer in Q4 2020 was Wasatch Advisors, an estimated $9.73M added.
  • The largest BioDelivery Sciences International, Inc. seller in Q4 2020 was Adage Capital Partners, an estimated $7.27M sold.

Based on aggregated 13F filings for Q4 2020.